We comparatively analyzed imbibition of polystyrene (PS) into two complementary pore models having pore diameters of ∼380 nm and hydroxyl-terminated inorganic-oxidic pore walls, controlled porous glass (CPG) and self-ordered porous alumina (AAO), by X-ray computed tomography and EDX spectroscopy. CPG contains continuous spongy-tortuous pore systems. AAO containing arrays of isolated straight cylindrical pores is a reference pore model with a tortuosity close to 1. Comparative evaluation of the spatiotemporal imbibition front evolution yields important information on the pore morphology of a probed tortuous matrix like CPG and on the imbibition mechanism. To this end, pixel brightness dispersions in tomographic 3D reconstructions and 2D EDX maps of infiltrated AAO and CPG samples were condensed into 1D brightness dispersion profiles normal to the membrane surfaces. Their statistical analysis yielded positions and widths of the imbibition fronts without segmentation or determination of pore positions. The retardation of the imbibition front movement with respect to AAO reference samples may be used as a descriptor for the tortuosity of a tested porous matrix. The velocity of the imbibition front movements in CPG equaled two-thirds of the velocity of the imbibition front movements in AAO. Moreover, the dynamics of the imbibition front broadening discloses whether porous matrices are dominated by cylindrical neck-like pore segments or by nodes. Independent single-meniscus movements in cylindrical AAO pores result in faster imbibition front broadening than in CPG, in which a morphology dominated by nodes results in slower cooperative imbibition front movements involving several menisci. The results presented here may be relevant to applications including printing and adhesive bonding, as well as to the optimization of production and properties of engineering, construction, and hybrid materials.
Transdermal drug delivery systems (TDDSs) play important roles in therapy due to distinct advantages over other forms and types of drug application. While common TDDS patches mainly consist of polymeric matrices so far, inorganic carriers show numerous advantages such as high mechanical stability, possible re-use and re-loading of drugs, and a broad chemical compatibility with therapeutically relevant compounds and chemical enhancers. Mesoporous glasses can be prepared in different monolithic shapes, and offer a particularly wide range of possible pore volumes, pore diameters, and specific surface areas. Further, they show high loading capacities and favorable physical, technical, and biological properties. Here, we explored for the first time monolithic SiO2-based carriers as sustained release systems of therapeutic drugs. In an ideally stirred vessel as model system, we systematically analyzed the influence of pore diameter, pore volume, and the dimensions of glass monoliths on the loading and sustained release of different drugs, including anastrozole, xylazine, imiquimod, levetiracetam, and flunixin. Through multilinear regression, we calculated the influence of different parameters on drug loading and diffusion coefficients. The systematic variation of the mesoporous glass properties revealed pore volumes and drug loading concentrations, but not pore diameter or pore surface area as important parameters of drug loading and release kinetics. Other relevant effectors include the occurrence of lateral diffusion within the carrier and drug-specific properties such as adsorption. The structure–property relationships derived from our data will allow further fine-tuning of the systems according to their desired properties as TDDS, thus guiding towards optimal systems for their use in transdermal drug applications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.